Elidah

Elidah is a private, commercial-stage medical device company targeting the significant and underserved market of female urinary incontinence with its flagship product, ELITONE. The device offers a unique, non-intrusive, wearable form of pelvic floor muscle stimulation, differentiating it from traditional internal pelvic floor trainers and invasive surgical options. The company employs a direct-to-consumer (DTC) e-commerce model, leveraging educational content and online assessments to drive awareness and sales. Elidah operates in a high-growth market but faces challenges from established competitors, reimbursement hurdles, and the need to demonstrate long-term clinical efficacy to both consumers and healthcare providers.

Wearable, non-intrusive, transcutaneous electrical stimulation device for pelvic floor muscle rehabilitation.

Elidah competes in the urinary incontinence device market against large medtech companies (e.g., Medtronic, Boston Scientific) offering implantable neuromodulation, numerous internal pelvic floor trainers (e.g., Kegel8, INNOVO), and absorbent product giants. Its primary differentiation is its external, wearable form factor, positioning it as a more comfortable and discreet alternative to internal devices.